Does Series 3 Platform’s PSA Level 4 Security Certification Change the Bull Case for Silicon Labs (SLAB)?

• At its recent Works With Summit, Silicon Labs announced the worldwide availability of its Series 3 platform, launching the SiMG301 and SiBG301 SoCs built on a 22 nm process, with advanced multi-core architecture, enhanced compute, and new security features.
• The SiMG301 introduces the industry's first PSA Level 4 security certification for edge devices, enabling device makers to address stricter global compliance demands while accelerating development cycles in smart home and building applications.
• We'll now examine how the Series 3 launch and its industry-first security certification could reshape Silicon Labs' investment narrative.

AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Silicon Laboratories Investment Narrative Recap

For Silicon Labs, the core investment thesis centers around capturing value from rapid growth in smart home and industrial IoT through leadership in secure, multi-protocol wireless chips. The Series 3 launch, featuring the world’s first PSA Level 4 security certification, directly strengthens this position, but does not immediately address competition risks or margin pressures, which remain the key short-term catalyst and risk for the business, respectively.

Of the company’s recent news, the Series 3 Secure Vault’s top-tier PSA Level 4 certification aligns squarely with rising regulatory demands, positioning Silicon Labs to win more premium projects that prioritize device security and compliance, an increasingly visible catalyst as cybersecurity standards tighten across key global markets.

By contrast, it is important for investors to be aware that while technological leadership can open doors, Silicon Labs still faces ongoing risks from intensifying competition that could...

Read the full narrative on Silicon Laboratories (it's free!)

Silicon Laboratories' narrative projects $1.2 billion revenue and $13.9 million earnings by 2028. This requires 19.2% yearly revenue growth and a $118.5 million earnings increase from current earnings of -$104.6 million.

Uncover how Silicon Laboratories' forecasts yield a $150.44 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members have posted fair value estimates for Silicon Labs ranging from US$79 to US$150, with just two perspectives represented. While some are optimistic about advanced wireless launches, others caution that margin pressures from competition could strongly influence profitability. Explore these viewpoints for a wider understanding of diverging expectations.

Explore 2 other fair value estimates on Silicon Laboratories - why the stock might be worth 41% less than the current price!

Build Your Own Silicon Laboratories Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Silicon Laboratories research is our analysis highlighting 1 key reward that could impact your investment decision.
• Our free Silicon Laboratories research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Silicon Laboratories' overall financial health at a glance.

No Opportunity In Silicon Laboratories?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com